![Cecilia Jones](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Cecilia Jones
Finanzdirektor/CFO bei
AGIOS PHARMACEUTICALS, INC.
Vermögen: 2 Mio $ am 31.05.2026
Profil
Cecilia Jones is currently Chief Financial Officer at Agios Pharmaceuticals, Inc. since 2022.
Formerly, Ms. Jones was Treasurer, Chief Financial & Accounting Officer at LogicBio Therapeutics, Inc. from 2021 to 2022, Senior Director-Corporate Finance at Biogen, Inc. from 2015 to 2019, and Director-International Finance at Genzyme Corp.
from 2003 to 2009.
Ms. Jones completed undergraduate studies at the University of San Andres and earned an MBA from Harvard Business School.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 02.04.2026 | 54 998 ( 0,09 % ) | 2 Mio $ | 31.05.2026 |
Aktive Positionen von Cecilia Jones
| Unternehmen | Position | Beginn |
|---|---|---|
| AGIOS PHARMACEUTICALS, INC. | Finanzdirektor/CFO | 26.09.2022 |
Ehemalige bekannte Positionen von Cecilia Jones
| Unternehmen | Position | Ende |
|---|---|---|
| LOGICBIO THERAPEUTICS, INC. | Finanzdirektor/CFO | 23.09.2022 |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Corporate Officer/Principal | 01.11.2009 |
| BIOGEN INC. | Corporate Officer/Principal | - |
Ausbildung von Cecilia Jones
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
71
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Agios Pharmaceuticals, Inc.
 Agios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics | Health Technology |
University of San Andres
 University of San Andres Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
LogicBio Therapeutics, Inc.
 LogicBio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines and therapies for bone metabolism, cardiology, neurology and rare diseases | Health Technology |
